undamentalytics Newsletter
Sign in

Biofrontera Inc. balance sheet

At the end of fiscal 2025, Biofrontera Inc. had total assets of $28.6m, total liabilities of $18.1m and shareholders' equity of $10.5m. It held $6.4m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents825171665
Receivables—————76
Inventory74711711
Total current assets20464323211812
Total assets24535128222924
Accounts payable011————
Total current liabilities4142118121211
Short-term debt———4———
Total debt0004000
Total liabilities18422723181818
Shareholders' equity6112454106
Shares outstanding———2m—12m14m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BFRI vs CPIXAQST vs BFRIBFRI vs IMCC

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Biofrontera Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biofrontera Inc.